Charulata Jindal

Associate Professor​

Email Address: charulata.jindal@iiphb.org
ORCID ID: 0000-0001-9522-9702
Academic Qualifications: PhD, MMSc, MSc, GCSRT
Research Areas: Communicable and Non-communicable disease epidemiology
Number of Publications: 40

List of Your Publications (selected/all)

  1. Pierce E, Jindal C, Choi Y, Efird J. Mycobacterium avium subspecies paratuberculosis (MAP) and non-solar uveal melanoma: An intriguing but inconclusive hypothesis. Transl Cancer Res 2022 doi: 10.21037/ter-22-2540. PMID in process.
  2. Efird J, Jindal C, Podder T, Kang K, Biswas, T. Cone beam computed tomography—the need for future guidance. J Thorac Dis 2022;14:3681-3683. PMID: 36389331.
  3. Fane L, Efird J, Jindal C, Biswas T. Dermatological Autoimmune Considerations of Immune Checkpoint Therapy. Biomedicines2022;10(10):2339. PMID: 36289601.
  4. Efird J, Jindal C, Biswas T. On the frontiers of breast cancer diagnosis and treatment: Current and future directions in a rapidly changing field. Medicina 2022;58(8):1026. PMID: 36013493.
  5. Fane L, Biswas T, Jindal C, Efird J. Breast Cancer Disparities in Asian-American Women: A Perspective Overview. Int J Environ Res Public Health2022;19(16):9790. PMID: 36011424.
  6. Efird J, Anderson E, Jindal C, Suzuki A. Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature. Curr Pharm Des2022;28:1695-1702. PMID: 35440302.
  7. Efird J, Anderson E, Jindal C, Redding T, Thompson A, Press A, Upchurch J, Williams C, Choi Y, Suzuki A. The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2. Int J Environ Res Public Health2021;19(1):447. PMID: 35010701
  8. Bith-Melander P, Ratliff J, Poisson C, Jindal C, Choi Y, Efird J. Slow burns: A qualitative study of burn pit and toxic exposures among military veterans serving in Afghanistan, Iraq and throughout the Middle East. Ann Psychiatry Clin Neurosci2021;4(1):1042. PMID: 35128459.
  9. Biswas T, Gawdi R, Jindal C, Iyer S, Kang KH, Bajor D, Machtay M, Choi Y, Efird J. Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: confirmatory results from the PROCLAIM phase III clinical trial. J Thorac Dis2021;13:5617-5626. PMID: 34795912.
  10. Sheikh S, Dey A, Datta S, Podder T, Jindal C, Dowlati A, Efird J, Machtay M, Biswas T. Role of radiation in extensive stage small cell lung cancer: A National Cancer Database registry analysis. Future Oncol2021;17:2713-2724. PMID: 33960209.
  11. Kang K, Efird J, Podder T, Zhang Y, Dowlati A, Machtay M, Jindal C, Biswas T. A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation. Int J Environ Res Public Health2021;18(6):3241. PMID: 33801033.
  12. Biswas T, Kang K, Gawdi R, Bajor D, Machtay M, Jindal C, Efird J. Using the Systemic Immune-Inflammation Index (SII) as a Mid-Treatment Marker for Survival among Patients with Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int J Environ Res Public Health2020;17(21):7995. PMID: 33143164.
  13. Jindal C, Kumar S, Sharma S, Choi Y, Efird J. The Prevention and Management of COVID-19: Seeking a Practical and Timely Solution. Int J Environ Res Public Health2020;17(11):3986. PMID: 32512826.
  14. Poisson C, Boucher S, Selby D, Ross SP, Jindal C, Efird J, Bith-Melander P. A Pilot Study of Airborne Hazards and Other Toxic Exposures in Iraq War Veterans. Int J Environ Res Public Health2020;17(9):3299. PMID: 32397395.
  15. Jindal C, Buch A, Efird J. Anti-inflammatory medications and coronary artery disease. Eur J Prev Cardiol2019;26:149-151. PMID: 31766878.
  16. Biswas T, Jindal C, Fitzgerald T, Efird J. Pathologic complete response (pCR) and survival of women with inflammatory breast cancer (IBC): An analysis based on biologic subtypes and demographic characteristics. Int J Environ Res Public Health2019;16(1):124. PMID: 30621221.
  17. Horne C, Goda T, Nifong L, Kypson A, O’Neal W, Kindell L, Jindal C, Efird J. Factors Associated with Discharge to a Skilled Nursing Facility after Transcatheter Aortic Valve Replacement Surgery.  Int J Environ Res Public Health2018;16(1):73. PMID: 30597877.
  18. Efird, J, Jindal C, Fitzgerald T, Biswas T. Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure? Transl Gastroenterol Hepatol2018, 3, 58, doi:10.21037/tgh.2018.08.06. PMID: 30363693.
  19. Efird J, Jindal C, Ferguson T. Update on the long-term cost-effectiveness of on-pump and off-pump coronary artery bypass grafting. Int J Cardiol2018;273:92-93, PMID: 30287059.
  20. Fitzgerald T, Hunter L, Mosquera C, Jindal C, Biswas T, Zervos E, Efird J. A simple matrix to predict treatment success and long-term survival among patients undergoing pancreatectomy. HPB (Oxford)2018,21:204-211. PMID: 30087052.
  21. Efird J, Hunter S, Chan S, Jeong S, Thomas S; Jindal, C.; Biswas, T. The Association between Age, Comorbidities and Use of Radiotherapy in Women with Breast Cancer: Implications for Survival. Medicines (Basel)2018;5(3):62. PMID: 29941817.
  22. Efird J, Jindal C, Kiser A, Akhter S, Crane P,  Kypson A, Sverdlov A, Davies S, Kindell L, Anderson E. Increased risk of atrial fibrillation among patients undergoing coronary artery bypass graft surgery while receiving nitrates and antiplatelet agents. J Int Med Res2018;46, 3183-3194. PMID: 29808744.
  23. Efird J, Jindal C. Using a Counting Process Method to Impute Censored Follow-Up Time Data. Int J Environ Res Public Health2018;15(4):690. PMID: 29621186.
  24. Biswas T, Efird J, Prasad S, Jindal C, Walker P. The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer. Oncotarget2017;8:112712-112719. PMID: 29348858.
  25. Hong M, Varghese R, Jindal C, Efird J. Refugee Policy Implications of U.S. Immigration Medical Screenings: A New Era of Inadmissibility on Health-Related Grounds. Int J Environ Res Public Health2017;14 (10). PMID: 28946650
  26. Bith-Melander P, Chowdhury N, Jindal C, Efird J. Trauma Affecting Asian-Pacific Islanders in the San Francisco Bay Area. Int J Environ Res Public Health2017;14 (9):1053. PMID: 28895918.
  27. Milton A, Rahman M, Hussain, S, Jindal C, Choudhury S, Akter S, Ferdousi S, Mouly T, Hall J, Efird J. Trapped in Statelessness: Rohingya Refugees in Bangladesh. Int J Environ Res Public Health 2017;14 (8):942. PMID: 28825673.
  28. Grubb W, Young R, Efird J, Jindal C, Biswas T. Local therapy for triple-negative breast cancer: a comprehensive review. Future Oncol (London, England)2017;13:1721-1730. PMID: 28776394.
  29. Fitzgerald T, Efird J, Bellamy N, Russo S, Jindal C, Mosquera C, Holliday E, Biswas T. Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients. Cancer2017;123:2909-2917. PMID: 28386965.
  30. Efird J, Kiser A, Crane P, Landrine H, Kindell L, Nelson M, Jindal C, Sarpong D, Griffin W, Ferguson T, Chitwood W, Davies S, Kypson A, Gudimella P, Anderson E. Perioperative inotrope therapy and atrial fibrillation following coronary artery bypass graft surgery: Evidence of a racial disparity. Pharmacotherapy2017;37:297-304. PMID: 28052357.
  31. Jindal C, Goel H. Reply to cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res2010;36(4):921. PMID: 20666972.
  32. Jindal C, Kumar S, Choudhary G, Goel H, Mittal B. Organic Anion Transporter Protein (OATP-C) Encoded by SLCO1B1 Gene Polymorphism (388A>G) and Susceptibility in Gallbladder Stone Disease. Indian J Med Res2009;129(2):170-5.